Pharmaxis Mutual Funds | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Pharmaxis Ltd.

Pharmaxis Ltd. | Mutual Funds

Mutual Funds that own Pharmaxis Ltd.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Nestor Australien Fonds

1,428,281

0.4%

0

2.25%

06/29/2018

About Pharmaxis

View Profile

Address	20 Rodborough Road Sydney New South Wales (NSW) 2086 Australia
Employees	-
Website	http://www.pharmaxis.com.au
Updated	07/08/2019
Pharmaxis Ltd. operates as a specialty pharmaceutical company, which engages in the development and commercialization of therapeutic products for chronic respiratory disorders, autoimmune diseases, and improved lung function test. It operates through the following segments: Bronchitol and Aridol Business and New Drug Development. The Bronchitol and Aridol Business segment covers the ongoing clinical development, manufacture, and sale of the Bronchitol and Aridol globally.